Log in to save to my catalogue

Down‐regulated miR‐331–5p and miR‐27a are associated with chemotherapy resistance and relapse in leu...

Down‐regulated miR‐331–5p and miR‐27a are associated with chemotherapy resistance and relapse in leu...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4394226

Down‐regulated miR‐331–5p and miR‐27a are associated with chemotherapy resistance and relapse in leukaemia

About this item

Full title

Down‐regulated miR‐331–5p and miR‐27a are associated with chemotherapy resistance and relapse in leukaemia

Publisher

Oxford, UK: Blackwell Publishing Ltd

Journal title

Journal of cellular and molecular medicine, 2011-10, Vol.15 (10), p.2164-2175

Language

English

Formats

Publication information

Publisher

Oxford, UK: Blackwell Publishing Ltd

More information

Scope and Contents

Contents

Multidrug resistance (MDR) and disease relapse are challenging clinical problems in the treatment of leukaemia. Relapsed disease is frequently refractory to chemotherapy and exhibits multiple drug resistance. Therefore, it is important to identify the mechanism by which cancer cells develop resistance. In this study, we used microRNA (miRNA) microa...

Alternative Titles

Full title

Down‐regulated miR‐331–5p and miR‐27a are associated with chemotherapy resistance and relapse in leukaemia

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4394226

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4394226

Other Identifiers

ISSN

1582-1838

E-ISSN

1582-4934

DOI

10.1111/j.1582-4934.2010.01213.x

How to access this item